2m 2m 2m 2m 2m 2m 2m
Aclaris Therap (ACRS)
NASDAQ
$3.52+$0.24 (+7.29%)
Price as of Oct 16, 2026 7:47 PM EDT- $482.8MMarket Cap
- 72.63%1-Year Change
- BiotechnologyIndustry
Aclaris Therap (ACRS)
$3.52+$0.24 (+7.29%)
ACRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.28 | ||
Change | -$0.21 (-6.02%) | ||
Open | $3.51 | ||
High | $3.53 | ||
Low | $3.25 | ||
Previous Close | $3.49 | ||
Volume | 2,457,047 | ||
30-Day Average Volume | 3,938,573 | ||
1-Week Change | -14.36% | ||
1-Month Change | -38.35% | ||
1-Year Change | 72.63% | ||
3-Year Change | -41.01% | ||
5-Year Change | -80.49% | ||
Fundamentals | |||
Shares Outstanding | 147.2M | ||
Total Assets | $179.7M | ||
Market Cap | $482.8M | ||
Enterprise Value | $463.6M | ||
Period: QTR TTM FY | |||
Revenue | $356,000.00 | ||
Net Income | -$21.5M | ||
Free Cash Flow | -$19.9M | ||
EBIT | -$21.5M | ||
EBITDA | -$21.4M | ||
Net Working Capital | $69.5M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -22 | ||
Enterprise Value/Revenue | 1,302 | ||
P/B | 4 | ||
P/E | -22 | ||
PEG | N/A | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue